Showing 1-6 of 6 grants

Title Institution Researcher Program Duration Total Award Amount
Intranasal combination therapy with preproinsulin-Fc and CD3 antibody for T1D prevention Institut Necker Sylvaine You Cures 01-October-2022 to 30-September-2025 $253,000.00
Predicting Early Islet Graft Success: A Clinical-Omics Platform for Donor and Stem-Cell–Derived Therapies INSERM Francois Pattou Cures 01-August-2025 to 31-July-2027 $748,640.92
Elucidating the role of secretory leukocyte protease inhibitor in type 1 diabetes. INSERM Julien Diana Cures 01-June-2022 to 31-May-2025 $441,650.00
Benign beta-cell autoimmunity: mechanisms, biomarkers and therapeutic targeting by PD-1 agonist antibodies to prevent type 1 diabetes INSERM Sylvaine You Cures 01-April-2025 to 31-March-2028 $330,880.00
STABILOOP Centre Hospitalier Université Grenoble Alpes Sandrine LABLANCHE Improving Lives 01-October-2024 to 30-September-2029 $511,998.95
Prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes related complications: the SFDT1 study APHP Hopital Lariboisiere Jean-Pierre Riveline Improving Lives 01-July-2023 to 30-June-2026 $900,000.00